Work

P2‐310: Exebryl‐1: A novel small‐molecule drug that markedly reduces amyloid plaque load and improves memory, enters human clinical trials

Year: 2008

Type: article

Source: Alzheimer s & Dementia

DOI: 10.1016/j.jalz.2008.05.1387

Authors: Alan D. Snow, Joel A. Cummings, Thomas P. Lake, Luke A. Esposito, F. Michael Hudson, Qubai Hu, Judy A. Cam, Jocelyn R. Aker, Steve Runnels

Institution: ProteoTech (United States)

Language: English

Topic: Alzheimer's disease research and treatments

Subfield: Physiology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W1976312485

FWCI: 0.226

Cites:

Cited by: 2

Related to: 10